Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2010
07/29/2010US20100189816 Cachexia prevention supplement
07/29/2010US20100189785 Use of D-ribose for fatigued subjects
07/29/2010US20100189773 5-cyano-4- (pyrrolo [2,3] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/29/2010US20100189770 Bioerodible patch
07/29/2010US20100189769 Polypeptide Films and Methods
07/29/2010US20100189695 Irak-1 as regulator of diseases and disorders
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010US20100189684 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
07/29/2010US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability
07/29/2010US20100189653 Pyrone analogs for therapeutic treatment
07/29/2010US20100189646 Carbazole Derivatives as Functional 5-HT6 Ligands
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/29/2010CA2750561A1 Compositions and methods for silencing apolipoprotein c-iii expression
07/29/2010CA2749930A1 Bridged and fused heterocyclic antidiabetic compounds
07/29/2010CA2749891A1 Bridged and fused antidiabetic compounds
07/29/2010CA2749700A1 Benzodiazepin-2-on derivatives
07/29/2010CA2749663A1 Pentafluorosulpholane-containing antidiabetic compounds
07/29/2010CA2749123A1 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
07/29/2010CA2748593A1 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use
07/29/2010CA2748587A1 Substituted pyrazinone amides
07/29/2010CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010CA2746902A1 A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without thenegative side effects of a mega dose nutritional supplement
07/29/2010CA2746832A1 Phosphate management with small molecules
07/28/2010EP2210886A1 Pyrimidyl indoline compound
07/28/2010EP2210880A1 Benzoxazinone derivative
07/28/2010EP2210876A1 Heterocyclic compound
07/28/2010EP2210872A1 New crystalline form III of agometalin, the process for its preparation and pharmaceutical compositions containing it
07/28/2010EP2210609A1 Agent for promoting the secretion of adiponectin and/or inhibiting the decrease in the secretion of adiponectin
07/28/2010EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein
07/28/2010EP2210601A1 Anti-fatigue agent comprising amino acid composition
07/28/2010EP2210600A1 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine
07/28/2010EP2210504A1 Composition comprising chicoric acid and/or derivatives thereof
07/28/2010EP2210503A1 Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight
07/28/2010EP2209780A2 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf- kappa b activity and use thereof
07/28/2010EP2209778A1 Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
07/28/2010EP2209774A1 Pyrimidinedione derivatives
07/28/2010EP2209768A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof
07/28/2010EP2209528A1 Rapid acting injectable insulin compositions
07/28/2010EP2209486A1 A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1
07/28/2010EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/28/2010EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents
07/28/2010CN1905875B The use of quaternary pyridinium salts as vasoprotective agents
07/28/2010CN1833727B Use of Arab gum in setting up animal's model and lowering blood cholestenone
07/28/2010CN101790531A Process for the preparation of pyrido [2, 1-a] isoquinoline derivatives and polymorphic froms thereof
07/28/2010CN101790521A Substituted piperazines as cb1 antagonists
07/28/2010CN101787379A Preparation of microbial oil containing polyunsaturated fatty acids
07/28/2010CN101787073A Methods and compositions for the treatment of gastrointestinal disorders
07/28/2010CN101787072A Specific binding agents of human angiopoietin-2
07/28/2010CN101787049A Novel crystal form of cocarboxylase tetrahydrate and preparation method thereof
07/28/2010CN101787029A Long-chain alkyl coptisine halate derivative, synthesis method and application
07/28/2010CN101787016A Pyridine carboxamides as 11-beta-hsd1 inhibitors
07/28/2010CN101787007A Dimeric sesquiterpene compound and applications thereof
07/28/2010CN101786978A 2-lactamine derivative
07/28/2010CN101786953A Kaurane-type diterpenoid compound as well as preparation method and medical application thereof
07/28/2010CN101785831A Preparation method of rice bran dietary fiber
07/28/2010CN101785815A Health care product with auxiliary functions on blood fat reduction and chemical liver injury protection
07/28/2010CN101785813A Chinese herba preparation for regulating lipid and reducing weight
07/28/2010CN101785803A Composition for suppressing cyclooxygenase and/or 5-lipoxygenase
07/28/2010CN101785802A Cinnamomum japonicum phenolic compound and preparation method and application thereof
07/28/2010CN101785800A Traditional Chinese medicine combination for hepatopathy treatment
07/28/2010CN101785794A Pharmaceutical composite and application thereof
07/28/2010CN101785789A Method for preparing animal gall powder
07/28/2010CN101785781A Medicine combination of levoamlodipine or medicinal salt of levoamlodipine and auricularia auricula polysaccharide, and application thereof
07/28/2010CN101785780A Preparation of cyanocobalamine and adenosine composition and preparation method thereof
07/28/2010CN101785774A Compound niacin simvastatin bilayer sustained-release tablet
07/28/2010CN101785763A Metformin hydrochloride enteric-coated sustained release tablet and preparation method thereof
07/28/2010CN101785553A Chicory capsule food and production method thereof
07/28/2010CN101785512A Health protection tea not only having nutrition and health protection roles, but also capable of preventing diseases and assisting for treating diseases
07/28/2010CN101245112B Polyoses extracted from pistacia chinensis meal and extracting method thereof
07/28/2010CN101224253B Chinese traditional medicine compounds for treating diabetic foot and preparing method thereof
07/28/2010CN101138578B Application of eucommia lignans and extract thereof in the preventing and controlling of diabetes complication
07/28/2010CN101095724B Technics for extracting lotus leaf flavone
07/28/2010CN101081091B Vision-improving and intelligent-improving beverage
07/28/2010CN101062283B Tea for reducing blood sugar and its preparing method
07/28/2010CN101062282B Tea having functions of treating hyperlipidemia and high cholesterol and the preparing method thereof
07/28/2010CN101015386B Soft aloinose and preparation method thereof
07/27/2010US7763747 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
07/27/2010US7763729 Bicyclic heteroaromatic derivatives
07/27/2010US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases
07/27/2010US7763662 reducing weight in mammals; Substituted with a thio, sulfoxy or sulfonyl group eg 5-Chloro-2-methylsulfonylindan-1-ol, 5-Chloro-2-(propane-2-sulfonyl)indan-1-ol, 5-Chloro-2-ethanesulfonylindan-1-ol
07/27/2010US7763623 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
07/27/2010US7763618 Pyridyl derivatives and their use as therapeutic agents
07/27/2010US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors
07/27/2010US7763601 Using O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime (BGP-15); weight loss
07/27/2010US7763278 As cholesterol lowering agents and for treatment of cardiovascular disorders
07/27/2010US7763255 Therapeutic uses of Dunaliella powder
07/27/2010CA2475025C Solid composition for oral or rectal administration having a melting point of 25.degree.c or higher and comprising a mixture of polar glycolipids and non-polar lipids
07/27/2010CA2470105C Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
07/27/2010CA2444266C Use of bile acid or bile salt fatty acid conjugates
07/27/2010CA2436659C Cannabinoid receptor ligands
07/27/2010CA2404000C A functional assay of high-density lipoprotein
07/22/2010WO2010083409A1 Companion animal compositions including pyruvic acid and salts thereof and methods of use thereof
07/22/2010WO2010083280A2 Methods for treating obesity and disorders associated with hyperlipidemia in a mammal
07/22/2010WO2010083279A2 Methods for treating disorders associated with hyperlipidemia in a mammal
07/22/2010WO2010083207A2 Protein kinase c inhibitors and uses thereof
07/22/2010WO2010083034A1 Methods for increasing adiponectin
07/22/2010WO2010082906A1 Use of nerium oleander for diseases manifested with type ii diabetes, obesity, high cholesterol and triglyceride
07/22/2010WO2010082821A1 Method of treating cancer
1 ... 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 ... 1298